AMTX vs LIN · rev $77.2M vs P/E 34, rev $33.99B
Aemetis Inc (AMTX) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Aemetis Inc (AMTX) is a specialty chemicals company listed on US.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported AMTX revenue for 2023-12-31 was $77.2M. Net income was -$46.4M. Revenue was up 174.6% from 2022-12-31 to 2023-12-31. AMTX currently screens at market cap $158.3M.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
AMTX currently screens at market cap $158.3M. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the AMTX and LIN stock pages for the full models.
Not investment advice.